|
|
|
|
|
|
|
|
 |
|
 |
A sample list of molecular EQA programmes available from QCMD is displayed below. For further information, to register or to access our catalogue please login to your QCMD Laboratory Profile. If you do not have a Username and Password please click here. Click to view / hide Blood Borne Virus B19 virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV034116_1 | QAV034116_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 8 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
HBV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124160_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV134167_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214221_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV024131_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114146_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
HIV-1 DNA EQA programme | Feature | Available Formats | | Catalogue Number | QAV034114_1 | QAV034114_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 8 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Hepatitis A virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124156_1 | QAV124156_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 8 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Hepatitis B Virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV994110_1 | QAV994110_2 | QAV994110_4 | | Total Number of Challenges | 1 | 2 | 4 | | Number of Panel Members | 8 | 4 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214223_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Hepatitis B virus Genotype EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064118_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214222_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Hepatitis C Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV994112_1 | QAV994112_2 | QAV994112_4 | | Total Number of Challenges | 1 | 2 | 4 | | Number of Panel Members | 8 | 4 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Hepatitis C virus Genotype EQA Programme| Feature | Available Formats | | Catalogue Number | QAV034117_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
Hepatitis D Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144170_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q4 |
Hepatitis E virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124157_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q4 |
Human Immunodeficiency Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV994108_1 | QAV994108_2 | QAV994108_4 | | Total Number of Challenges | 1 | 2 | 4 | | Number of Panel Members | 8 | 4 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 | Q1, Q2, Q3 & Q4 |
Human Immunodeficiency Virus Type 2 EQA Programme| Feature | Available Formats | | Catalogue Number | QAV204212_1 | QAV204212_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 8 | 4 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Click to view / hide Central Nervous System Arthropod-Borne Viruses EQA Programme| Feature | Available Formats | | Catalogue Number | QAM194206_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144166_1 | QAV144166_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Borrelia burgdorferi spp. DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB114147_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV174195_1 | QAV174195_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174196_1 | QAM174196_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Chikungunya Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV154175_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114148_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Enterovirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV984104_1 | QAV984104_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Enterovirus Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164185_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164184_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV994105_1 | QAV994105_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
JC virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV074106_1 | QAV074106_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Measles and Mumps EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144171_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Parechovirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114145_1 | QAV114145_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Toxoplasma gondii DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAP044123_1 | QAP044123_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Varicella-Zoster virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV034103_1 | QAV034103_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
West Nile Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV104141_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Zika Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164186_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Click to view / hide Congenital Infections Cytomegalovirus Dried Blood Spot EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064127_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Toxoplasma gondii DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAP044123_1 | QAP044123_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214217_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Click to view / hide Drug Resistance Cytomegalovirus Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144169_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Extended Spectrum β-lactamase and Carbapenemase EQA Programme| Feature | Available Formats | | Catalogue Number | QAB134162_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
HBV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124160_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV134167_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV024131_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114146_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
Herpes Simplex Virus Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164184_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q1 |
Methicillin Resistant Staphylococcus aureus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB064124_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAB194209_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Vancomycin Resistant Enterococci EQA Programme| Feature | Available Formats | | Catalogue Number | QAB134163_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Click to view / hide Exotic / Emerging Diseases Plasmodium spp. (Malaria) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214218_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Arthropod-Borne Viruses EQA Programme| Feature | Available Formats | | Catalogue Number | QAM194206_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214219_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Chikungunya Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV154175_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Dengue Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114148_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAB214220_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
MERS Coronavirus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV154181_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q2 |
Respiratory I Plus EQA Programme| Feature | Available Formats | | Catalogue Number | QAM204216_1A | QAM204216_1B | | Total Number of Challenges | 1 | 1 | | Number of Panel Members | 10 | 10 | | Distribution / Testing Period | Q2 | Q4 |
SARS-CoV-2 Antigen Testing EQA Programme | Feature | Available Formats | | Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D | | Total Number of Challenges | 1 | 1 | 1 | 1 | | Number of Panel Members | 5 | 5 | 5 | 5 | | Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme| Feature | Available Formats | | Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D | | Total Number of Challenges | 1 | 1 | 1 | 1 | | Number of Panel Members | 5 | 5 | 5 | 5 | | Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214217_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
West Nile Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV104141_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Yellow Fever Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV194207_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Zika Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164186_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Click to view / hide Gastrointestinal Diseases Adenovirus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054133_1 | QAV054133_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Bacterial Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAB124153_1 | QAB124153_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Clostridium difficile DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB084125_1 | QAB084125_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Diarrheagenic Escherichia coli EQA Programme| Feature | Available Formats | | Catalogue Number | QAB154179_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Helicobacter pylori EQA Programme| Feature | Available Formats | | Catalogue Number | QAB164190_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Norovirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV084139_1 | QAV084139_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Parasitic Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAP124154_1 | QAP124154_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Viral Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124152_1 | QAV124152_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide Immunocompromised Associated Diseases Aspergillus spp. DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAF104140_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
BK virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144166_1 | QAV144166_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Babesia spp. (Babesiosis) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214219_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Candida spp. EQA Programme| Feature | Available Formats | | Catalogue Number | QAF124151_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144169_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124150_1 | QAV124150_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV024121_1 | QAV024121_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme| Feature | Available Formats | | Catalogue Number | QAV134161_1 | QAV134161_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV014120_1 | QAV014120_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV084119_1 | QAV084119_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV074106_1 | QAV074106_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAF114144_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Torque Teno Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV184203_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 6 | | Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAP044123_1 | QAP044123_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174198_1 | QAM174198_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214217_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Click to view / hide Multiple Pathogen/Syndromic Arthropod-Borne Viruses EQA Programme| Feature | Available Formats | | Catalogue Number | QAM194206_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Bacterial Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAB124153_1 | QAB124153_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System I (Viral Meningitis and Encephalitis) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV174195_1 | QAV174195_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Central Nervous System II (Non-Viral Meningitis and Encephalitis) EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174196_1 | QAM174196_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB174191_1 | QAB174191_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
MALDI-TOF EQA Programme| Feature | Available Formats | | Catalogue Number | QAB124155_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Parasitic Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAP124154_1 | QAP124154_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Respiratory I EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164188_1 | QAV164188_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme| Feature | Available Formats | | Catalogue Number | QAM204216_1A | QAM204216_1B | | Total Number of Challenges | 1 | 1 | | Number of Panel Members | 10 | 10 | | Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164189_1 | QAV164189_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174193_1 | QAM174193_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Sepsis EQA Programme| Feature | Available Formats | | Catalogue Number | QAB164178_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Sexually Transmitted Infections I EQA Programme| Feature | Available Formats | | Catalogue Number | QAB154177_1 | QAB154177_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174201_1 | QAM174201_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Transplantation EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174198_1 | QAM174198_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Viral Gastroenteritis EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124152_1 | QAV124152_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide Respiratory Diseases Adenovirus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054133_1 | QAV054133_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Atypical Mycobacterium EQA Programme| Feature | Available Formats | | Catalogue Number | QAB194208_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q1 |
Bordetella pertussis DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB094132_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q2 |
Chlamydia psittaci EQA Programme| Feature | Available Formats | | Catalogue Number | QAB134165_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q2 |
Chlamydophila pneumoniae EQA Programme| Feature | Available Formats | | Catalogue Number | QAB084107_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Coronavirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064137_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q2 |
Influenza Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064138_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q4 |
Influenza virus A and B RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054134_1 | QAV054134_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Legionella pneumophila DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB044122_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q1 |
MERS Coronavirus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV154181_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q2 |
Measles and Mumps EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144171_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Metapneumovirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054135_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q2 |
Mycobacterium Tuberculosis Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAB194209_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Mycobacterium tuberculosis DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB014129_1 | QAB014129_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Mycoplasma pneumoniae EQA Programme| Feature | Available Formats | | Catalogue Number | QAB174192_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Parainfluenza Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064136_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q2 |
Pneumocystis jirovecii pneumonia (PCP) DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAF114144_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Respiratory I EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164188_1 | QAV164188_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory I Plus EQA Programme| Feature | Available Formats | | Catalogue Number | QAM204216_1A | QAM204216_1B | | Total Number of Challenges | 1 | 1 | | Number of Panel Members | 10 | 10 | | Distribution / Testing Period | Q2 | Q4 |
Respiratory II EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164189_1 | QAV164189_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory III EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174193_1 | QAM174193_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Respiratory Syncytial Virus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054142_1 | QAV054142_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Rhinovirus RNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064143_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q2 |
SARS-CoV-2 Antigen Testing EQA Programme | Feature | Available Formats | | Catalogue Number | QAS214224_1A | QAS214224_1B | QAS214224_1C | QAS214224_1D | | Total Number of Challenges | 1 | 1 | 1 | 1 | | Number of Panel Members | 5 | 5 | 5 | 5 | | Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
SARS-CoV-2 EQA Programme| Feature | Available Formats | | Catalogue Number | QAV204215_1A | QAV204215_1B | QAV204215_1C | QAV204215_1D | | Total Number of Challenges | 1 | 1 | 1 | 1 | | Number of Panel Members | 5 | 5 | 5 | 5 | | Distribution / Testing Period | Q1 | Q2 | Q3 | Q4 |
Click to view / hide Sexually Transmitted Infections Chlamydia trachomatis DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB004101_1 | QAB004101_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Chlamydia trachomatis and Neisseria gonorrhoeae DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB174191_1 | QAB174191_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Herpes Simplex Virus Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164184_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q1 |
Herpes simplex virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV994105_1 | QAV994105_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Preservcyt) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV094130_1 | QAV094130_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 12 | 6 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Human Papillomavirus (Surepath) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV184204_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 12 | | Distribution / Testing Period | Q3 |
Mycoplasma genitalium EQA Programme| Feature | Available Formats | | Catalogue Number | QAB184205_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Neisseria gonorrhoeae DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAB034126_1 | QAB034126_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Sexually Transmitted Infections I EQA Programme| Feature | Available Formats | | Catalogue Number | QAB154177_1 | QAB154177_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Sexually Transmitted Infections II EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174201_1 | QAM174201_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Syphilis EQA Programme| Feature | Available Formats | | Catalogue Number | QAB154180_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Trichomonas vaginalis EQA Programme| Feature | Available Formats | | Catalogue Number | QAP184202_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Click to view / hide Transplant Associated Diseases Adenovirus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV054133_1 | QAV054133_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
BK virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144166_1 | QAV144166_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Cytomegalovirus Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144169_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Cytomegalovirus Whole Blood EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124150_1 | QAV124150_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV024121_1 | QAV024121_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Epstein-Barr virus Whole Blood EQA Programme| Feature | Available Formats | | Catalogue Number | QAV134161_1 | QAV134161_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Cytomegalovirus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV014120_1 | QAV014120_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Human Herpes Virus 6 DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV084119_1 | QAV084119_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
JC virus DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAV074106_1 | QAV074106_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Torque Teno Virus EQA Programme| Feature | Available Formats | | Catalogue Number | QAV184203_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 6 | | Distribution / Testing Period | Q4 |
Toxoplasma gondii DNA EQA Programme| Feature | Available Formats | | Catalogue Number | QAP044123_1 | QAP044123_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q3 | Q1 & Q3 |
Transplantation EQA Programme| Feature | Available Formats | | Catalogue Number | QAM174198_1 | QAM174198_2 | | Total Number of Challenges | 1 | 2 | | Number of Panel Members | 10 | 5 | | Distribution / Testing Period | Q4 | Q2 & Q4 |
Click to view / hide Typing Bacterial 16S EQA Programme| Feature | Available Formats | | Catalogue Number | QAB164183_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Cytomegalovirus Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV144169_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q2 |
Enterovirus Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164185_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
HBV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV124160_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HCV Drug Resistance Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV134167_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
HIV Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV024131_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
HIV Drug Resistance (Integrase) EQA Programme| Feature | Available Formats | | Catalogue Number | QAV114146_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q4 |
Hepatitis B virus Genotype EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064118_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
Hepatitis C virus Genotype EQA Programme| Feature | Available Formats | | Catalogue Number | QAV034117_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q1 |
Herpes Simplex Virus Drug Resistance EQA Programme| Feature | Available Formats | | Catalogue Number | QAV164184_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q1 |
Influenza Typing EQA Programme| Feature | Available Formats | | Catalogue Number | QAV064138_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q4 |
MALDI-TOF EQA Programme| Feature | Available Formats | | Catalogue Number | QAB124155_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Methicillin Resistant Staphylococcus aureus Typing (epidemiology and outbreak studies) EQA Programme| Feature | Available Formats | | Catalogue Number | QAB074128_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Staphylococcus aureus spa EQA Programme| Feature | Available Formats | | Catalogue Number | QAB134164_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 6 | | Distribution / Testing Period | Q3 |
Click to view / hide EQA Pilots Plasmodium spp. (Malaria) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214218_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Babesia spp. (Babesiosis) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214219_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Francisella tularensis EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAB214220_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
HIV Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214221_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Hepatitis B Virus Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214223_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Hepatitis C Virus Dried Blood Spot EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV214222_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 8 | | Distribution / Testing Period | Q3 |
Trypanosoma cruzi (Chagas disease) EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAP214217_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 10 | | Distribution / Testing Period | Q3 |
Viral Metagenomics NGS EQA Pilot Study| Feature | Available Formats | | Catalogue Number | QAV204213_1 | | Total Number of Challenges | 1 | | Number of Panel Members | 5 | | Distribution / Testing Period | Q3 |
|
|
|
|
Unit 5, Technology
Terrace, Todd Campus, West of Scotland Science Park Glasgow
G20 0XA Scotland, UK
Tel: +44 (0)141 945 6474 Fax:
+44 (0)141 945 5795 Enquiry Form
|
|
|
|
|
